Recent studies have found sofosbuvir, which is used in the treatment of Hepatitis C virus infection, to be effective in treating Zika virus. Preliminary experiments conducted in mice show that the drug effectively reduces the load of Zika in the blood and prevents transmission of the virus from the mother to the fetus. A recent study published in Scientific Reports has demonstrated that the antiviral drug sofosbuvir, which is used in treating Hepatitis C virus (HCV) infection, can be repurposed for the treatment of Zika. This finding is significant at a time when scientific research is being directed towards finding a suitable vaccine candidate for Zika.
However, the need to develop clinical strategies for the treatment of the disease cannot be overlooked. The drug “Sofobuvir” Sofosbuvir, a nucleotide analog, inhibits the replication of HCV. The drug has already been approved and…
